about
Localized fetomaternal hyperglycemia: spatial and kinetic definition by positron emission tomographyHyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis.Angiotensin II-induced cardiovascular load regulates cardiac remodeling and related gene expression in late-gestation fetal sheep.Programming of adult cardiovascular disease following exposure to late-gestation hyperglycemia.The effect of adrenalectomy on the cardiac response to subacute fetal anemia.Effect of insulin and dexamethasone on fetal assimilation of maternal glucose.Maternal Hyperglycemia Directly and Rapidly Induces Cardiac Septal Overgrowth in Fetal Rats.ANG II modulation of cardiac growth and remodeling in immature fetal sheep.Maternal Hyperglycemia Disrupts Histone 3 Lysine 36 Trimethylation of the IGF-1 Gene.Thyroid hormone is required for growth adaptation to pressure load in the ovine fetal heartSex-specific programming of hypertension in offspring of late-gestation diabetic ratsUrinary metabolomic markers of aminoglycoside nephrotoxicity in newborn ratsCoronary constriction to angiotensin II is enhanced by endothelial superoxide production in sheep programmed by dexamethasone.Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice.Neonatal growth restriction-related leptin deficiency enhances leptin-triggered sympathetic activation and central angiotensin II receptor-dependent stress-evoked hypertension.Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.Genotype-specific alterations in vascular smooth muscle cell function in cystic fibrosis piglets.Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.Renal adaptive changes and sodium handling in the fetal-to-newborn transition.Increasing fetal ovine number per gestation alters fetal plasma clinical chemistry values.Regulation of myocardial glucose transporters GLUT1 and GLUT4 in chronically anemic fetal lambs.Endothelial superoxide production is altered in sheep programmed by early gestation dexamethasone exposure.Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity.Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism.Myocardial vascular and metabolic adaptations in chronically anemic fetal sheep.Impact of the ovarian cycle and pregnancy on plasma chemistry values in ewes.Differential gene expression and regulation of renal angiotensin II receptor subtypes (AT1 and AT2) during fetal life in sheep.Causes and circumstances of death in a neonatal unit over 20 years.Ovine uterine space restriction causes dysregulation of the renin-angiotensin system in fetal kidneys.Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart.Ontogeny of vascular growth factors in perinatal sheep myocardium.Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep.Ontogenic changes and regulation of renal angiotensin II type 1 receptor gene expression during fetal and newborn life.Activation of the mitogen-activated protein kinases and Akt in response to pulmonary artery banding in the fetal sheep heart is developmentally regulated.Hemodynamic Changes during Endotracheal Suctioning Are Mediated by Increased Autonomic ActivityRole of sympathetic activity in the generation of heart rate and arterial pressure variability in fetal sheepMetabolic adaptation of the hypertrophied heart: role of the malate/aspartate and alpha-glycerophosphate shuttlesChanges in body water compartments with diuretic therapy in infants with chronic lung diseaseAutonomic adjustments to severe hypotension in fetal and neonatal sheepMyocardial apoptosis after cardioplegic arrest in the neonatal lamb
P50
Q27321833-D7E135B1-0051-46E8-A6FF-C4E4EE50071DQ33796342-A17D47BA-8C4F-4E01-88EA-DCB65B0B6578Q34609798-473641C8-C7F0-4EB9-8F10-22EA1CD6BF68Q34891946-9453A3C9-3D67-4DF5-8BEC-4341B5DD99A5Q34992234-826069F8-CADF-4364-8810-B265CD1FC939Q35558465-850648B2-313F-4190-9F89-895E83DD1DB8Q35630501-D6B89438-0852-4110-BC85-8E15B5AA6E44Q35672002-5755A734-6A26-4ED5-939B-DAC434636D53Q35884853-056F84CA-29C4-4C75-9B23-3B7CFD0862F1Q36626105-31EDC561-ED73-4DAA-868D-FB24C0E57F84Q36713830-63402F7E-4BE4-4828-8198-69C43138484FQ36807292-36C85916-8B69-4F67-B195-F9AF2FCCDA80Q36873843-A31A4934-D2F1-4C55-9563-3908F3700D22Q37151068-ABD1C2EA-D5C4-471E-9416-6ABD084547C4Q37187914-74DFC2B8-1A52-49A5-8F22-766E965B0714Q37316394-AC805EE8-EB40-449F-87C9-B62F71411642Q37678474-343783DA-E389-4909-B84B-495E0B1B1D9AQ37985080-1953C1ED-FC25-4E4C-AEAD-4287B70BCD03Q39018368-131C5D5E-5A39-4E89-9612-E9BC10CB853DQ40964696-E017C03F-0EFA-4BC0-8CC8-37FFE1A2658BQ42484626-BBE8F9E6-8A7F-4D9C-82B0-60DB9FF872A6Q42515858-7F294FAF-EFAD-4430-93F5-4F645C534AC4Q44951848-D7C6752D-1A25-4C47-8742-D805469B5445Q45199018-D183CB4D-662C-4C5C-BFCB-F2CA9B1C7442Q46669990-0879DB91-8FF5-41CC-9FF1-A562D48FEA06Q47226708-7CEEC3F4-D739-412C-9EBF-1783CD5F609AQ48068739-8717E69F-2ABA-453B-9104-AFE4318B15CFQ50009365-EA99A673-E3EE-432B-9392-993E9DD33D0BQ50445135-4C77738C-1542-4070-8F32-884F4D034F5FQ52033655-4EAC9EC6-CE9D-46EC-9FC7-D0CB04E80021Q52085091-044D9674-E6F4-444B-B814-DEBECA7B5F27Q52184810-4EB2AB04-78BB-4FAC-860A-B7FE51211925Q52212510-98E32D53-FEF6-42EA-B02B-2C95A8E4BC10Q53526851-8F864701-2763-4C80-8F1A-DE8F6EE337D5Q60731541-8741D2A9-4182-425B-8C97-450E25B887ACQ72379890-FB601065-6E57-406F-BAAD-C4EB3E870565Q73288483-C1CC8D8E-7EED-4FF7-910B-F4CFAB300C03Q73297636-ECD3C12B-07E7-498A-A11F-FCFEA4085B16Q73337346-C82878D3-D4AC-41AA-B5DF-CEF959CA3451Q73582644-AF8493CF-A59D-438C-AB8C-43DE126211B3
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Jeffrey L Segar
@ast
Jeffrey L Segar
@en
Jeffrey L Segar
@es
Jeffrey L Segar
@nl
type
label
Jeffrey L Segar
@ast
Jeffrey L Segar
@en
Jeffrey L Segar
@es
Jeffrey L Segar
@nl
prefLabel
Jeffrey L Segar
@ast
Jeffrey L Segar
@en
Jeffrey L Segar
@es
Jeffrey L Segar
@nl
P106
P1153
7005682618
P31
P496
0000-0001-7311-8948